The Deleterious Influence of Tenofovir-Based Therapies on the Progression of Atherosclerosis in HIV-Infected Patients

被引：8

作者：

Aragones, Gerard ^{[1
]}

Pardo-Reche, Pedro ^{[2
]}

Fernandez-Sender, Laura ^{[2
]}

Rull, Anna ^{[1
]}

Beltran-Debon, Raul ^{[1
]}

Rodriguez-Gallego, Esther ^{[1
]}

Camps, Jordi ^{[1
]}

Joven, Jorge ^{[1
]}

Alonso-Villaverde, Carlos ^{[1
]}

机构：

[1] Univ Rovira & Virgili, Hosp Univ St Joan, Unitat Recerca Biomed URB CRB, IISPV, Reus 43201, Spain

[2] Univ Rovira & Virgili, Hosp Univ St Joan, Med Interna Serv, IISPV, Reus 43204, Spain

来源：

MEDIATORS OF INFLAMMATION | 2012年 / 2012卷

关键词：

MONOCYTE CHEMOATTRACTANT PROTEIN-1; REDUCES ATHEROSCLEROSIS; LIPOPROTEIN; CELLS; RISK; INFLAMMATION; MACROPHAGE; EXPRESSION; OXIDATION; ABACAVIR;

D O I：

10.1155/2012/372305

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

We investigated the potential differential effects of antiretroviral therapies on unbalanced chemokine homeostasis and on the progression of atherosclerosis in HIV-infected patients. A two-year prospective study was performed in 67 consecutive HIV-infected patients initiating antiretroviral therapy with abacavir/lamivudine or tenofovir/emtricitabine. Circulating levels of inflammatory biomarkers, progression of subclinical atherosclerosis and expression levels of selected chemokines genes in circulating leukocytes were assessed. Control subjects showed significantly lower plasma concentrations of CRP, tPA, IL-6, and MCP-1 than HIV-infected patients at a baseline. After two years of followup, the observed decreases in plasma inflammatory biomarker levels were only significant for MCP-1, tPA, and IL-6. The decrease in plasma MCP-1 concentration was associated with the progression of atherosclerosis, and this effect was negligible only in patients receiving TDF-based therapy. Multivariate analysis confirmed that treatment with TDF was positively and significantly associated with a higher likelihood of subclinical atherosclerosis progression. However, the expression levels of selected genes in blood cells only showed associations with the viral load and total and HDL-cholesterol levels. Current antiretroviral treatments may partially attenuate the influence of HIV infection on certain inflammatory pathways, though patients receiving TDF therapy must be carefully monitored with respect to the presence and/or progression of atherosclerosis.

引用

页数：9

共 39 条

[1] Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: Role of peripheral blood mononuclear cells and implications for AIDS pathogenesis [J].

Ahmad, R ;

Sindhu, STA ;

Toma, E ;

Morisset, R ;

Ahmad, A .

JOURNAL OF VIROLOGY, 2002, 76 (24) :12448-12456

[2] High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy [J].

Alonsa-Villaverde, C ;

Segues, T ;

Coll-Crespo, B ;

Pérez-Bernalte, R ;

Rabassa, A ;

Gomila, M ;

Parra, S ;

Gozález-Estebana, AA ;

Jiménez-Expósito, J ;

Masana, L .

AIDS, 2003, 17 (08) :1173-1178

[3] Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele [J].

Alonso-Villaverde, C ;

Coll, B ;

Parra, S ;

Montero, M ;

Calvo, N ;

Tous, M ;

Joven, J ;

Masana, L .

CIRCULATION, 2004, 110 (15) :2204-2209

[4] Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity [J].

Aragones, Gerard ;

Beltran-Debon, Raul ;

Rull, Anna ;

Rodriguez-Sanabria, Fernando ;

Fernandez-Sender, Laura ;

Camps, Jordi ;

Joven, Jorge ;

Alonso-Villaverde, Carlos .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2010, 48 (08) :1147-1152

[5] Diet and lifestyle are associated with serum C-reactive proteins concentrations in a population-based study [J].

Bertran, N ;

Camps, J ;

Fernandez-Ballart, J ;

Arija, V ;

Ferre, N ;

Tous, M ;

Simo, D ;

Murphy, MM ;

Vilella, E ;

Joven, J .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (01) :41-46

[6] High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans [J].

Birjmohun, Rakesh S. ;

van Leuven, Sander I. ;

Levels, Johannes H. M. ;

van 't Veer, Cornelis ;

Kuivenhoven, Jan Albert ;

Meijers, Joost C. M. ;

Levi, Marcel ;

Kastelein, John J. P. ;

van der Poll, Tom ;

Stroes, Erik S. G. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (05) :1153-1158

[7] Carotid intima-media thickness measurements in intervention studies - Design options, progression rates, and sample size considerations: A point of view [J].

Bots, ML ;

Evans, GW ;

Riley, WA ;

Grobbee, DE .

STROKE, 2003, 34 (12) :2985-2994

[8] HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial [J].

Calmy, Alexandra ;

Gayet-Ageron, Angele ;

Montecucco, Fabrizio ;

Nguyen, Alain ;

Mach, Francois ;

Burger, Fabienne ;

Ubolyam, Sasiwimol ;

Carr, Andrew ;

Ruxungtham, Kiat ;

Hirschel, Bernard ;

Ananworanich, Jintanat .

AIDS, 2009, 23 (08) :929-939

[9] The stromal derived factor-1 mutated allele (SDF1-3′A,) is associated with a lower incidence of atherosclerosis in HIV-infected patients [J].

Coll, B ;

Alonso-Villaverde, C ;

Parra, S ;

Montero, M ;

Tous, M ;

Joven, J ;

Masana, L .

AIDS, 2005, 19 (16) :1877-1883

[10] The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection [J].

Coll, Blai ;

Parra, Sandra ;

Alonso-Villaverde, Carlos ;

Aragones, Gerard ;

Montero, Manuel ;

Camps, Jordi ;

Joven, Jorge ;

Masana, Lluis .

STROKE, 2007, 38 (09) :2477-2484

← 1 2 3 4 →